Latest News about Merck & Co Inc
Recent news which mentions Merck & Co Inc
From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
   
  
  April 25, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Monday
   
  
  April 22, 2024
  From CNBC.com News
 
   Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech
   
  
  April 19, 2024
  From CNBC.com News
 
   FDA approves Merck's drug for rare, deadly lung condition
   
  
  March 26, 2024
  From CNBC.com News
 
   Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
   
  
  March 19, 2024
  From CNBC.com News
 
   Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
   
  
  March 13, 2024
  From CNBC.com News
 
   Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
   
  
  March 10, 2024
  From CNBC.com News
 
   New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
   
  
  February 23, 2024
  From CNBC.com News
 From CNBC.com News
 
   Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
   
  
  February 13, 2024
  From CNBC.com News
 
   Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
   
  
  February 08, 2024
  From CNBC.com News
 
   Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
   
  
  February 02, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   5 things to know before the stock market opens Monday
   
  
  January 29, 2024
  From CNBC.com News
 
   Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
   
  
  January 28, 2024
  From CNBC.com News
 
   Cramer's week ahead: Fed meeting, labor report, Big Tech earnings
   
  
  January 26, 2024
  From CNBC.com News
 
   Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
   
  
  January 26, 2024
  From CNBC.com News
 
   Dow goes from 37,000 to 38,000 in just 40 days. A history of the Dow and big round numbers
   
  
  January 23, 2024
  From CNBC.com News
 
   Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
   
  
  January 14, 2024
  From CNBC.com News
 
   J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
   
  
  January 08, 2024
  From CNBC.com News
 
   Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
   
  
  January 02, 2024
  From CNBC.com News
 
   Biden administration's Medicare drug price negotiations will face major tests in 2024
   
  
  December 28, 2023
  From CNBC.com News
 From CNBC.com News
 
   Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
   
  
  December 14, 2023
  From CNBC.com News
 
   Pfizer shares fall as 2024 revenue and profit forecast disappoints
   
  
  December 13, 2023
  From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
